Ashland Research Technology Inc (ARTI) offers consulting and specialized services for drug R&D, with a focus on bioanalysis, DMPK, and automation and optimzation of bioanalysis and DMPK workflow.
ARTI is led by Stacy Ho, PhD, an industry-recognized expert with 30 years of experience spanning discovery, preclinical development, and clinical support for phases 1–4. Dr. Ho has directed large bioanalysis and DMPK organizations in global pharma, built new bioanalytial laboratories and teams from the ground up, and contributed to multiple successful IND, NDA, and ANDA filings worldwide.
Ashland Research Technology Inc
Sponsors work with ARTI when they need to:
With deep scientific expertise and a proven track record of operational innovation, ARTI helps you generate reliable data, shorten cycle times, and make confident development decisions.
Suspendisse potenti Phasellus euismod libero in neque molestie et mentum libero maximus. Etiam in enim vestibulum suscipit sem quis molestie nibh.
Suspendisse potenti Phasellus euismod libero in neque molestie et mentum libero maximus. Etiam in enim vestibulum suscipit sem quis molestie nibh.
Lorem ipsum dolor sit amet consectetur adipiscing elit sed do eiusmod tempor incididunt ut labore et dolore.
Suspendisse potenti Phasellus euismod libero in neque molestie et mentum libero maximus. Etiam in enim vestibulum suscipit sem quis molestie nibh.
